Discover 1,576 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,576
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
for
Small Cell Lung Cancer Metastatic or Locally Advanced,
Location: New York NY, Hackensack NJ, New Brunswick NJ,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT07080242
Phase 1, Recruiting
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
for
Follicular Lymphoma
Location: New York NY, Hackensack NJ, Cleveland OH, Durham NC,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07634471
Phase 2, Phase 3, Recruiting
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: New York NY, Hackensack NJ, Boston MA, Buffalo NY,
Sponsor: NextCure, Inc.
Sex: All
Age: 18+
Code: NCT06792552
Phase 1, Recruiting
A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons
for
Open Surgery, Lymphedema, Free Tissue Transfer, Microsurgery,
Location: New York NY, Hackensack NJ, New Haven CT, Buffalo NY,
Sponsor: MMI (Medical Microinstruments, Inc.)
Sex: All
Age: 22+
Code: NCT06725030
Recruiting
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
for
Heart Failure
Location: New York NY, Bridgewater NJ, Yardley PA, Baltimore MD,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06935370
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
for
Prostate Cancer
Location: New York NY, The Bronx NY, Philadelphia PA,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT06780670
Phase 2, Phase 3, Recruiting
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
for
Systemic Lupus Erythematosus (With and Without Nephritis),
Location: New York NY, East Brunswick NJ, Baltimore MD, Montreal,
Sponsor: Allogene Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07085104
Phase 1, Recruiting
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: New York NY, Morristown NJ, Waltham MA, Cleveland OH,
Sponsor: AbbVie
Sex: All
Age: 2 - 17
Code: NCT05995353
Phase 3, Recruiting
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
for
Diffuse Large B-Cell Lymphoma
Location: New York NY, Belleville NJ, Shirley NY, Albany NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06717347
Phase 3, Recruiting
A Phase 1/2 Study of IAM1363 in HER2 Cancers
for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: New York NY, New Brunswick NJ, Boston MA, Fairfax VA,
Sponsor: Iambic Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06253871
Phase 1, Phase 2, Recruiting
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels